These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20049645)

  • 1. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease.
    Cardona PJ
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):7-14. PubMed ID: 20049645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUTI: a new chance to shorten the treatment of latent tuberculosis infection.
    Cardona PJ
    Tuberculosis (Edinb); 2006; 86(3-4):273-89. PubMed ID: 16545981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Riddles in human tuberculous infection].
    Tsuyuguchi I
    Kekkaku; 2000 Oct; 75(10):603-9. PubMed ID: 11109776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms].
    Colakoğlu S
    Mikrobiyol Bul; 2004; 38(1-2):155-67. PubMed ID: 15293916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
    Salgame P
    Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pressure model of immune response to mycobacterium tuberculosis infection in several space dimensions.
    Clarelli F; Natalini R
    Math Biosci Eng; 2010 Apr; 7(2):277-300. PubMed ID: 20462290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune responses to M. tuberculosis infection.
    Natarajan K; Kundu M; Sharma P; Basu J
    Tuberculosis (Edinb); 2011 Sep; 91(5):427-31. PubMed ID: 21550855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is adipose tissue a place for Mycobacterium tuberculosis persistence?
    Neyrolles O; Hernández-Pando R; Pietri-Rouxel F; Fornès P; Tailleux L; Barrios Payán JA; Pivert E; Bordat Y; Aguilar D; Prévost MC; Petit C; Gicquel B
    PLoS One; 2006 Dec; 1(1):e43. PubMed ID: 17183672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis.
    Dannenberg AM
    Immunobiology; 1994 Oct; 191(4-5):461-73. PubMed ID: 7713560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the nature of Mycobacterium tuberculosis-latent bacilli.
    Cardona PJ; Ruiz-Manzano J
    Eur Respir J; 2004 Dec; 24(6):1044-51. PubMed ID: 15572551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity in tuberculosis.
    Chaparas SD
    Bull World Health Organ; 1982; 60(4):447-62. PubMed ID: 6814775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunology of tuberculosis].
    Tokunaga T
    Kekkaku; 1989 Feb; 64(2):121-33. PubMed ID: 2499728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The secret trumps, impelling the pathogenicity of tubercle bacilli.
    Cardona PJ; Ivanyi J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.
    Martinez V; Carcelain G; Badell E; Jouan M; Mauger I; Sellier P; Truffot C; Bricaire F; Arend SM; Ottenhoff T; Autran B; Gicquel B
    BMC Infect Dis; 2007 Jul; 7():83. PubMed ID: 17655752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis.
    Ha SJ; Jeon BY; Youn JI; Kim SC; Cho SN; Sung YC
    Gene Ther; 2005 Apr; 12(7):634-8. PubMed ID: 15690060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.